Nothing Special   »   [go: up one dir, main page]

ZA200104140B - Use of ibandronate for promoting osseointegration of endoprostheses. - Google Patents

Use of ibandronate for promoting osseointegration of endoprostheses.

Info

Publication number
ZA200104140B
ZA200104140B ZA200104140A ZA200104140A ZA200104140B ZA 200104140 B ZA200104140 B ZA 200104140B ZA 200104140 A ZA200104140 A ZA 200104140A ZA 200104140 A ZA200104140 A ZA 200104140A ZA 200104140 B ZA200104140 B ZA 200104140B
Authority
ZA
South Africa
Prior art keywords
endoprostheses
ibandronate
promoting osseointegration
osseointegration
promoting
Prior art date
Application number
ZA200104140A
Other languages
English (en)
Inventor
Frieder Bauss
Andreas A Kurth
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of ZA200104140B publication Critical patent/ZA200104140B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
ZA200104140A 1998-12-04 2001-05-21 Use of ibandronate for promoting osseointegration of endoprostheses. ZA200104140B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19855976 1998-12-04

Publications (1)

Publication Number Publication Date
ZA200104140B true ZA200104140B (en) 2002-08-21

Family

ID=7889968

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200104140A ZA200104140B (en) 1998-12-04 2001-05-21 Use of ibandronate for promoting osseointegration of endoprostheses.

Country Status (17)

Country Link
US (1) US6680307B1 (ko)
EP (2) EP1135140B1 (ko)
JP (1) JP3793023B2 (ko)
KR (1) KR100453779B1 (ko)
CN (1) CN1173704C (ko)
AR (1) AR020017A1 (ko)
AT (1) ATE303153T1 (ko)
AU (1) AU756540B2 (ko)
BR (1) BR9915927A (ko)
CA (1) CA2353528C (ko)
DE (1) DE69927048T2 (ko)
DK (1) DK1135140T3 (ko)
ES (1) ES2247842T3 (ko)
PT (1) PT1135140E (ko)
TR (1) TR200101546T2 (ko)
WO (1) WO2000033849A1 (ko)
ZA (1) ZA200104140B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004038A1 (en) * 2000-07-12 2002-01-17 Hopital Orthopedique De La Suisse Romande Active biocoating for bone implant
MXPA02001219A (es) * 2001-02-01 2005-06-06 Riderway Corp Composicion farmaceutica liquida para el tratamiento de enfermedades oseas.
JP2005514400A (ja) * 2001-12-21 2005-05-19 ザ プロクター アンド ギャンブル カンパニー 骨疾患の治療方法
ES2532393T3 (es) * 2002-05-10 2015-03-26 F. Hoffmann-La Roche Ag Acidos bisfosfónicos para tratamiento y prevención de osteoporosis
ES2291749T5 (es) * 2002-12-20 2011-07-21 F. Hoffmann-La Roche Ag Formulación de altas dosis de ibandronato.
EP1508343B1 (en) * 2003-08-21 2015-11-04 AddBIO AB Bisphosponate coated implant device and method therefor
EP2363401A1 (en) * 2005-02-01 2011-09-07 F. Hoffmann-La Roche AG Ibandronate polymorph B
AU2006210009B2 (en) * 2005-02-01 2009-08-13 F. Hoffmann-La Roche Ag Ibandronate polymorph A
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
WO1994014455A1 (en) * 1992-12-23 1994-07-07 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
AU5973496A (en) * 1995-06-06 1996-12-24 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
AU729793B2 (en) * 1996-12-13 2001-02-08 Zymogenetics Inc. Compositions and methods for stimulating bone growth

Also Published As

Publication number Publication date
CN1173704C (zh) 2004-11-03
KR20010093137A (ko) 2001-10-27
WO2000033849A1 (en) 2000-06-15
AU1557700A (en) 2000-06-26
PT1135140E (pt) 2005-10-31
US6680307B1 (en) 2004-01-20
ES2247842T3 (es) 2006-03-01
JP2002531509A (ja) 2002-09-24
JP3793023B2 (ja) 2006-07-05
ATE303153T1 (de) 2005-09-15
KR100453779B1 (ko) 2004-10-20
TR200101546T2 (tr) 2001-11-21
DK1135140T3 (da) 2005-12-19
BR9915927A (pt) 2001-08-21
AR020017A1 (es) 2002-03-27
DE69927048D1 (de) 2005-10-06
EP1135140A1 (en) 2001-09-26
CA2353528C (en) 2007-04-24
EP1135140B1 (en) 2005-08-31
EP1614422A3 (en) 2009-02-18
CA2353528A1 (en) 2000-06-15
EP1614422A2 (en) 2006-01-11
AU756540B2 (en) 2003-01-16
DE69927048T2 (de) 2006-06-08
CN1329495A (zh) 2002-01-02

Similar Documents

Publication Publication Date Title
AU2001255846A8 (en) Dental implant system
PL350796A1 (en) Compositions for promoting growth
IL129779A0 (en) Selective surface endosseous dental implants
GB9812103D0 (en) Surgical implant
TW481979U (en) Impression tray for dental prosthetics
IL140740A0 (en) Dental implant component
ZA200104140B (en) Use of ibandronate for promoting osseointegration of endoprostheses.
GB2357036B (en) Process for the preparation of dental prosthesis
ZA200110450B (en) Oral preparations of etidronate disodium.
GB2347865B (en) Cotyloid prosthesis
HUP0004776A3 (en) Prosthesis system
IL140327A0 (en) Dental implant component
AU138005S (en) Dental implant component
GB9904252D0 (en) Composition for the treatment of pain
AU137973S (en) Implant
GB9812066D0 (en) Prosthesis construction
GB9803645D0 (en) Cleaner for dental treatment
EP1175834A4 (en) METHOD OF USING BACTERICIDE COMPOSITION
TW462280U (en) Improved dental implant
AU138007S (en) Dental implant component
SI1068199T1 (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
GB9823744D0 (en) Compositions for promoting bone formation
GB9819585D0 (en) Biomechanical implant
GB9909722D0 (en) Compositions for promoting bone formation
GB9814241D0 (en) Medical implants